Growth Metrics

Iradimed (IRMD) Cash from Investing Activities Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Iradimed 1.17 Bn 1.11 Bn 16.81 Mn 88.03%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 88.03%
Dec 31, 2025 86.38%
Sep 30, 2025 68.50%
Jun 30, 2025 -122.41%
Mar 31, 2025 -718.08%
Dec 31, 2024 -383.07%
Sep 30, 2024 -813.73%
Jun 30, 2024 -235.64%
Mar 31, 2024 92.70%
Dec 31, 2023 -34.16%
Sep 30, 2023 21.07%
Jun 30, 2023 -587.76%
Mar 31, 2023 -1,443.94%
Dec 31, 2022 -281.57%
Sep 30, 2022 -152.14%
Jun 30, 2022 -90.09%
Mar 31, 2022 -144.17%
Dec 31, 2021 -13.56%
Sep 30, 2021 -99.67%
Jun 30, 2021 172.55%
Mar 31, 2021 24.50%
Dec 31, 2020 -67.87%
Sep 30, 2020 -108.07%
Jun 30, 2020 -15.33%
Mar 31, 2020 -141.34%
Dec 31, 2019 -12.93%
Sep 30, 2019 113.36%
Jun 30, 2019 182.35%
Mar 31, 2019 163.24%
Dec 31, 2018 170.91%
Sep 30, 2018 1,855.30%
Jun 30, 2018 -169.83%
Mar 31, 2018 443.04%
Dec 31, 2017 -153.76%
Sep 30, 2017 -134.37%
Jun 30, 2017 210.55%
Mar 31, 2017 93.27%
Dec 31, 2016 -511.78%
Sep 30, 2016 234.35%
Jun 30, 2016 -519.01%
Mar 31, 2016 -2,132.11%
Dec 31, 2015 101.81%
Sep 30, 2015 -123.05%
Jun 30, 2015 62.50%
Mar 31, 2015 -372.67%
Dec 31, 2014 -15,987.66%
Sep 30, 2014 61.84%